( Max-Planck-Gesellschaft ) The Max Planck Society, Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the ophthalmology division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
More...
More...